Medical News

RSS

Stimulating effect of bioactive collagen peptides in cell experiments demonstrated

Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.

15 Sep 2009

Mortality index can be misleading in major specialties

A key statistic that consumer groups and the media often use when compiling hospital report cards and national rankings can be misleading, researchers report in a new study.

15 Sep 2009

Children's sexuality linked to genetic influences: Study

Previous research has found that children raised in homes without a biological father have sex earlier than children raised in traditional nuclear families. Now a new study that used a novel and complex design to investigate why this is so challenges a popular explanation of the reasons.

15 Sep 2009

Loyola University receives funds to renovate bone marrow transplant unit

Loyola University Medical Center has received a $2 million matching grant from The Coleman Foundation to renovate the hospital's nationally known bone marrow transplant unit. Intended to encourage private donations for the project, the grant will match gifts up to $2 million on a dollar for dollar basis, through August 2010.

15 Sep 2009

CFAR to host AIDS Vaccine 2010 conferrence

The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research.

15 Sep 2009

eClinicalWorks uses EMC, RSA and VMware solutions to manage business growth

EMC Corporation (NYSE: EMC), the world leader in information infrastructure solutions, today announced that eClinicalWorks, a market leader in ambulatory clinical systems with more than 25,000 healthcare provider customers, has consolidated and enhanced security of its IT infrastructure using EMC, RSA and VMware solutions.

15 Sep 2009

Genetic switch that causes excessive mucus in the lungs identified

Scientists have identified the main genetic switch that causes excessive mucus in the lungs, a discovery that one day could ease suffering for people with chronic lung diseases like asthma and cystic fibrosis, or just those fighting the common cold.

15 Sep 2009

Positive results from Merck's Phase IIB clinical study of odanacatib for treating osteoporosis

New data from a Phase IIB clinical study of odanacatib, Merck & Co., Inc.'s oral, once-weekly investigational treatment for osteoporosis, showed that when stopping treatment after two years, the increases in lower back (lumbar spine) bone mineral density (BMD) were reversed over the next year, while BMD at the hip (femoral neck) remained above levels observed at the start of the study.

15 Sep 2009

Implementation of Alliance’s surgeon owned distribution model helps to save over $1.0 million

A scientific exhibit recently presented at the American Academy of Orthopedic Surgeons (AAOS) showed that by implementing a surgeon-owned distribution model, with Alliance Surgical Distributors (Alliance), three California hospitals saved over $1.0 million.

15 Sep 2009

Kelly Services offers EHR service

To address the growing need for the restructuring of healthcare records, Kelly Services, Inc. (NASDAQ: KELYA) today announced its Health Informatics service offering. Health Informatics is the intersection of information science, technology and healthcare and focuses on the application of computer information systems to healthcare and public health providers.

15 Sep 2009

Breast and ovarian cancer awareness campaign launched by Myriad Genetics

Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.

15 Sep 2009

HFSA's 13th Annual Scientific Meeting focuses on causes and treatment of heart failure

The Heart Failure Society of America's (HFSA) 13th Annual Scientific Meeting convened Sunday, September 13, 2009 at the Hynes Convention Center in Boston. This three-day meeting -- a forum for heart failure specialists to present research findings and advances in treatment -- will address emerging trends in research and new developments in the approach to treating patients with this condition.

15 Sep 2009

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

Mpex Pharmaceuticals, Inc. reported positive top line results from a Phase 2b clinical trial with Aeroquin, a novel aerosol formulation of levofloxacin delivered by an optimized Investigational eFlow Nebulizer System from PARI Pharma. In the Mpex cystic fibrosis trial, nebulized Aeroquin met the primary endpoint of reducing bacterial counts of Pseudomonas aeruginosa in sputum after 28 days of dosing versus placebo.

15 Sep 2009

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

With health officials nationwide already preparing for the upcoming cold and flu season, Environmental Solutions International (ESI) introduces Smart & Silky and Kids Smart & Silky Foaming Hand Sanitizers as another weapon in the illness-prevention arsenal. These unique, alcohol-free, moisturizing hand sanitizers are available at retailers nationwide (visit www.smartandsilky.com for more details).

15 Sep 2009

Excessive physical strain in dementia care linked to communication problems

Excessive physical strain in dementia care is not so much related to equipment or the resident's body weight as it is due to communication problems and misunderstandings. This is shown in a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

15 Sep 2009

Children with microcephaly should be screened for neurologic and cognitive problems, says guideline

A new guideline from the American Academy of Neurology, developed in full collaboration with the Child Neurology Society, finds that children with microcephaly that is, children whose head size is smaller than that of 97 percent of childrenare at risk of neurologic and cognitive problems and should be screened for these problems. The guideline is published in the September 15, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.

15 Sep 2009

Elsevier launches new web platform

Elsevier, the leading publisher of scientific, technical and medical information products and services, announced today the launch of a new web platform, Elsevier Mental Health (www.elseviermentalhealth.com).

15 Sep 2009

Pall Corporation announces financial results for the fourth quarter and fiscal year ended July 31, 2009

Pall Corporation (NYSE:PLL) today reported financial results for the fourth quarter and fiscal year ended July 31, 2009. Sales and net earnings for the year were $2.3 billion and $195.6 million, respectively. Diluted earnings per share (EPS) were $1.64, compared to $1.76 a year earlier. Pro forma EPS were $1.77 versus last year's $1.97.

From Pall Corporation 15 Sep 2009

Phase I results of Tobira's TBR-652 CCR5 antagonist for the treatment of HIV

Tobira Therapeutics Inc., a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from a double-blind, placebo-controlled, multiple-dose randomized study of TBR-652 in sixty healthy volunteers.

15 Sep 2009

Mellow Hope completes clinical trial of H1N1 vaccine, receives approval from SFDA

At the beginning of September, Mellow Hope completed the clinical trial of Influenza A (H1N1) Vaccine (Split Virion). The company received the clinical approval from the State Food and Drug Administration (SFDA) http://eng.sfda.gov.cn/eng. Production will be started shortly.

15 Sep 2009

Medical News

Stimulating effect of bioactive collagen peptides in cell experiments demonstrated

Mortality index can be misleading in major specialties

Children's sexuality linked to genetic influences: Study

Loyola University receives funds to renovate bone marrow transplant unit

CFAR to host AIDS Vaccine 2010 conferrence

eClinicalWorks uses EMC, RSA and VMware solutions to manage business growth

Genetic switch that causes excessive mucus in the lungs identified

Positive results from Merck's Phase IIB clinical study of odanacatib for treating osteoporosis

Implementation of Alliance’s surgeon owned distribution model helps to save over $1.0 million

Kelly Services offers EHR service

Breast and ovarian cancer awareness campaign launched by Myriad Genetics

HFSA's 13th Annual Scientific Meeting focuses on causes and treatment of heart failure

Phase 2b trial of Mpex's Aeroquin with PARI Pharma's eFlow Nebulizer System successful

Environmental Solutions International introduces unique, alcohol-free, moisturizing hand sanitizers

Excessive physical strain in dementia care linked to communication problems

Children with microcephaly should be screened for neurologic and cognitive problems, says guideline

Elsevier launches new web platform

Pall Corporation announces financial results for the fourth quarter and fiscal year ended July 31, 2009

Phase I results of Tobira's TBR-652 CCR5 antagonist for the treatment of HIV

Mellow Hope completes clinical trial of H1N1 vaccine, receives approval from SFDA

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News